These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8916249)

  • 1. Guidelines for the use of placebo controls in clinical trials of psychopharmacologic agents. Loma Linda University Institutional Review Board.
    Orr RD
    Psychiatr Serv; 1996 Nov; 47(11):1262-4. PubMed ID: 8916249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebos in clinical trials of psychotropic medication.
    Addington D; Williams R; Lapierre Y; el-Guebaly N
    Can J Psychiatry; 1997 Apr; 42(3):6p.. PubMed ID: 9114950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ethical implications of placebo-controlled clinical trials for psychotropic drugs].
    Helmchen H
    Nervenarzt; 2005 Nov; 76(11):1319-29. PubMed ID: 15812676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical considerations in neuroclinical trials.
    Macciocchi SN; Alves WA
    Neurosurg Rev; 1997; 20(3):161-70. PubMed ID: 9297717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebos, drug effects, and study design: a clinician's guide.
    Quitkin FM
    Am J Psychiatry; 1999 Jun; 156(6):829-36. PubMed ID: 10360119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled trials in psychiatric research: an ethical perspective.
    Miller FG
    Biol Psychiatry; 2000 Apr; 47(8):707-16. PubMed ID: 10773177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conflict-of-interest policies for investigators in clinical trials.
    Lo B; Wolf LE; Berkeley A
    N Engl J Med; 2000 Nov; 343(22):1616-20. PubMed ID: 11096170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective.
    Laughren TP
    Eur Psychiatry; 2001 Nov; 16(7):418-23. PubMed ID: 11728855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical problems and design of controlled clinical trials.
    Helmchen H
    Psychopharmacol Ser; 1990; 8():82-7. PubMed ID: 2377598
    [No Abstract]   [Full Text] [Related]  

  • 11. Conducting research with children: legal and ethical issues.
    Glantz LH
    J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1283-91. PubMed ID: 8885582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is the placebo still ethically acceptable and scientifically useful in clinical drug experimentation?].
    Mariani L; Ventresca GP
    Clin Ter; 1996 Nov; 147(11):595-8. PubMed ID: 9264914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
    Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL
    J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-ranging in clinical trials: rationale and proposed use with placebo or positive controls.
    Freston JW
    Am J Gastroenterol; 1986 May; 81(5):307-11. PubMed ID: 3706243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-controlled clinical trials in gastroenterology. A position paper of the American College of Gastroenterology.
    Sachar DB
    Am J Gastroenterol; 1984 Dec; 79(12):913-7. PubMed ID: 6507416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology.
    March J; Kratochvil C; Clarke G; Beardslee W; Derivan A; Emslie G; Green EP; Heiligenstein J; Hinshaw S; Hoagwood K; Jensen P; Lavori P; Leonard H; McNulty J; Michaels MA; Mossholder A; Osher T; Petti T; Prentice E; Vitiello B; Wells K
    J Am Acad Child Adolesc Psychiatry; 2004 Aug; 43(8):1046-56. PubMed ID: 15266201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of phase III psychotropic drug trials by intensive phase II work.
    Klein DF
    Neuropsychopharmacology; 1991 Jun; 4(4):251-8; discussion 259-71. PubMed ID: 1867735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Principles and regulations for clinical pilot studies on psycholeptic drugs (author's transl)].
    Woggon B; Angst J
    Arzneimittelforschung; 1978; 28(8):1257-9. PubMed ID: 380573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What makes placebo-controlled trials unethical?
    Miller FG; Brody H
    Am J Bioeth; 2002; 2(2):3-9. PubMed ID: 12189059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical drug research from medical ethics and legal perspectives].
    Ornek Büken N; Büken E
    Turk Psikiyatri Derg; 2003; 14(4):289-99. PubMed ID: 14704931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.